Viral Coinfection among COVID-19 Patient Groups: An Update Systematic Review and Meta-Analysis.
Viral Coinfection among COVID-19 Patient Groups: An Update Systematic Review and Meta-Analysis.
复制标题
DOI：
10.1155/2021/5313832
复制
发表时间：
2021
影响因子：
--
通讯作者：
Soltani S
中科院分区：
文献类型：
--
作者：
Malekifar P;Pakzad R;Shahbahrami R;Zandi M;Jafarpour A;Rezayat SA;Akbarpour S;Shabestari AN;Pakzad I;Hesari E;Farahani A;Soltani S
在大流行期间，合并感染在增加发病率和死亡率方面具有潜在作用。我们的调查旨在评估COVID-19患者中病毒合并感染的患病率。 我们系统检索了2019年12月1日至2020年12月30日期间的科学数据库，包括Medline、Scopus、WOS和Embase。还扫描了medRxiv等预印本服务器，以查找其他相关的预印本论文。考虑了评估COVID-19患者中病毒合并感染患病率的所有类型的研究。我们应用随机效应模型来汇总所有相关研究。 确定了33项研究，包括10484例患者。合并病毒感染的估计合并患病率为12.58%; 95%CI：7.31 - 18.96）。血液病毒（合并患病率：12.48%; 95%CI：8.57 - 16.93）是最常见的病毒合并感染，呼吸道病毒（合并患病率：4.32%; 95%CI：2.78 - 6.15）的病毒合并感染频率较低。疱疹病毒合并患病率为11.71%（95%CI：3.02 ~ 24.80）。此外，AMRO和EMRO的合并病毒感染患病率最高和最低，分别为15.63%（95%CI：3.78至33.31）和7.05%（95%CI：3.84至11.07）。 呼吸道病毒的合并感染率最低。混合感染率最高的是血源性病毒。我们的研究结果提供了关于COVID-19患者中血液传播病毒流行率的重要数据，这对于他们的治疗程序至关重要。
Coinfections have a potential role in increased morbidity and mortality rates during pandemics. Our investigation is aimed at evaluating the viral coinfection prevalence in COVID-19 patients. We systematically searched scientific databases, including Medline, Scopus, WOS, and Embase, from December 1, 2019, to December 30, 2020. Preprint servers such as medRxiv were also scanned to find other related preprint papers. All types of studies evaluating the viral coinfection prevalence in COVID-19 patients were considered. We applied the random effects model to pool all of the related studies. Thirty-three studies including 10484 patients were identified. The viral coinfection estimated pooled prevalence was 12.58%; 95% CI: 7.31 to 18.96). Blood viruses (pooled prevalence: 12.48%; 95% CI: 8.57 to 16.93) had the most frequent viral coinfection, and respiratory viruses (pooled prevalence: 4.32%; 95% CI: 2.78 to 6.15) had less frequent viral coinfection. The herpesvirus pooled prevalence was 11.71% (95% CI: 3.02 to 24.80). Also, the maximum and minimum of viral coinfection pooled prevalence were in AMRO and EMRO with 15.63% (95% CI: 3.78 to 33.31) and 7.05% (95% CI: 3.84 to 11.07), respectively. The lowest rate of coinfection belonged to respiratory viruses. Blood-borne viruses had the highest coinfection rate. Our results provide important data about the prevalence of blood-borne viruses among COVID-19 patients which can be critical when it comes to their treatment procedure.
登录
查看更多内容
影响因子：
8.1
作者：
Contou, Damien;Claudinon, Aurore;Plantefeve, Gaetan
通讯作者：
Plantefeve, Gaetan
DOI：
10.1016/j.cmi.2020.07.041
发表时间：
2021-01
期刊：
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
影响因子：
--
作者：
Garcia-Vidal C;Sanjuan G;Moreno-García E;Puerta-Alcalde P;Garcia-Pouton N;Chumbita M;Fernandez-Pittol M;Pitart C;Inciarte A;Bodro M;Morata L;Ambrosioni J;Grafia I;Meira F;Macaya I;Cardozo C;Casals C;Tellez A;Castro P;Marco F;García F;Mensa J;Martínez JA;Soriano A;COVID-19 Researchers Group
通讯作者：
COVID-19 Researchers Group
影响因子：
12.7
作者：
Ding, Qiang;Lu, Panpan;Liu, Mei
通讯作者：
Liu, Mei
影响因子：
11.8
作者：
Kuo SC;Tsou HH;Wu HY;Hsu YT;Lee FJ;Shih SM;Hsiung CA;Chen WJ
通讯作者：
Chen WJ
影响因子：
6.7
作者：
Butt, Adeel A.;Yan, Peng
通讯作者：
Yan, Peng